Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)
- Status
- COMPLETED
- Phase
- PHASE1
Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE1
CD19-redirected Autologous Cells (CAR-CD19 T Cells)
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
- Status
- COMPLETED
- Phase
- PHASE4
TIL Therapy for Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).
- Status
- UNKNOWN
- Phase
- PHASE1
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG
- Status
- COMPLETED
- Phase
- PHASE1
Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
- Status
- COMPLETED
- Phase
- PHASE1
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
- Status
- UNKNOWN
- Phase
- PHASE4
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
- Status
- COMPLETED
- Phase
- NA
Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
ACTolog in Patients With Solid Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE1